Operating characteristics of a Simon two-stage phase II clinical trial design incorporating continuous toxicity monitoring
{{output}}
Phase II clinical trials are usually designed to measure efficacy, but safety is also an important end point. Previous authors recommended a method to monitor toxic events after each patient is enrolled, which is also known as continuously monitoring the toxic... ...
